Quantinno Capital Management LP Eagle Pharmaceuticals, Inc. Transaction History

Quantinno Capital Management LP

  • $7.54 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019
SELL
$53.25 - $59.98 $282,651 - $318,373
-5,308 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$46.61 - $58.45 $223,961 - $280,852
-4,805 Reduced 47.51%
5,308 $296,000
Q1 2019

May 14, 2019
BUY
$38.66 - $51.82 $390,968 - $524,055
10,113 New
10,113 $511,000

Others Institutions Holding EGRX

# of Institutions
70
Shares Held
8.6M
Call Options Held
1M
Put Options Held
100
View Full List

About EAGLE PHARMACEUTICALS, INC.

EGRX Quotes by TradingView
  • Ticker EGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,015,900
  • Market Cap $7.81M
  • Description
  • Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...
More about EGRX
Track This Portfolio

Track Quantinno Capital Management LP Portfolio

Follow Quantinno Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantinno Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantinno Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email